Hypertension-induced organ damage in African americans

Transforming growth factor-β1 excess as a mechanism for increased prevalence

Phyllis August, Beth Leventhal, Manikkam Suthanthiran

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Hypertension is prevalent world-wide, and it affects over 50 million individuals in the United States alone. African Americans (blacks) have a high prevalence of hypertension, develop it at an earlier age, and suffer excessively from severe or malignant hypertension. They also have a high prevalence of target organ damage attributable to hypertension, including left ventricular hypertrophy, stroke, endstage renal disease (ESRD) and coronary artery disease. Hypertensive nephrosclerosis is particularly more prevalent in blacks compared to whites, and there is evidence that factors in addition to elevated blood pressure contribute to its pathogenesis. Transforming growth factor-beta 1(TGF-β1) is a fibrogenic cytokine that has been implicated in the development and progression of experimental and human renal diseases. We have demonstrated that blacks with ESRD have higher circulating levels of TGF-β1 protein compared to whites with ESRD. We have also found that hyperexpression of TGF-β1 is more frequent in blacks with hypertension than in whites. We propose that TGF-β1 hyperexpression may be an important mediator of hypertension and hypertensive nephrosclerosis. We hypothesize also that the increased frequency of TGF-β1hyperexpression may contribute to the excess burden of ESRD in blacks. Based on our hypotheses, and the observations that angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists reduce angiotensin II-mediated stimulation of TGF-β1 production, we propose that treatment with these agents might be efficacious in preventing or slowing the progression of target organ damage in hypertensive blacks.

Original languageEnglish
Pages (from-to)184-191
Number of pages8
JournalCurrent Hypertension Reports
Volume2
Issue number2
DOIs
Publication statusPublished - 1 Jan 2000
Externally publishedYes

Fingerprint

Transforming Growth Factors
African Americans
Transforming Growth Factor beta
Hypertension
Nephrosclerosis
Kidney
Malignant Hypertension
Angiotensin Receptor Antagonists
Left Ventricular Hypertrophy
Renal Artery
Angiotensin-Converting Enzyme Inhibitors
Angiotensin II
Coronary Artery Disease
Stroke
Cytokines
Blood Pressure
Proteins

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Hypertension-induced organ damage in African americans : Transforming growth factor-β1 excess as a mechanism for increased prevalence. / August, Phyllis; Leventhal, Beth; Suthanthiran, Manikkam.

In: Current Hypertension Reports, Vol. 2, No. 2, 01.01.2000, p. 184-191.

Research output: Contribution to journalArticle

@article{88635a85d6924565a23ccd896153456e,
title = "Hypertension-induced organ damage in African americans: Transforming growth factor-β1 excess as a mechanism for increased prevalence",
abstract = "Hypertension is prevalent world-wide, and it affects over 50 million individuals in the United States alone. African Americans (blacks) have a high prevalence of hypertension, develop it at an earlier age, and suffer excessively from severe or malignant hypertension. They also have a high prevalence of target organ damage attributable to hypertension, including left ventricular hypertrophy, stroke, endstage renal disease (ESRD) and coronary artery disease. Hypertensive nephrosclerosis is particularly more prevalent in blacks compared to whites, and there is evidence that factors in addition to elevated blood pressure contribute to its pathogenesis. Transforming growth factor-beta 1(TGF-β1) is a fibrogenic cytokine that has been implicated in the development and progression of experimental and human renal diseases. We have demonstrated that blacks with ESRD have higher circulating levels of TGF-β1 protein compared to whites with ESRD. We have also found that hyperexpression of TGF-β1 is more frequent in blacks with hypertension than in whites. We propose that TGF-β1 hyperexpression may be an important mediator of hypertension and hypertensive nephrosclerosis. We hypothesize also that the increased frequency of TGF-β1hyperexpression may contribute to the excess burden of ESRD in blacks. Based on our hypotheses, and the observations that angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists reduce angiotensin II-mediated stimulation of TGF-β1 production, we propose that treatment with these agents might be efficacious in preventing or slowing the progression of target organ damage in hypertensive blacks.",
author = "Phyllis August and Beth Leventhal and Manikkam Suthanthiran",
year = "2000",
month = "1",
day = "1",
doi = "10.1007/s11906-000-0080-5",
language = "English",
volume = "2",
pages = "184--191",
journal = "Current Hypertension Reports",
issn = "1522-6417",
publisher = "Current Medicine Group",
number = "2",

}

TY - JOUR

T1 - Hypertension-induced organ damage in African americans

T2 - Transforming growth factor-β1 excess as a mechanism for increased prevalence

AU - August, Phyllis

AU - Leventhal, Beth

AU - Suthanthiran, Manikkam

PY - 2000/1/1

Y1 - 2000/1/1

N2 - Hypertension is prevalent world-wide, and it affects over 50 million individuals in the United States alone. African Americans (blacks) have a high prevalence of hypertension, develop it at an earlier age, and suffer excessively from severe or malignant hypertension. They also have a high prevalence of target organ damage attributable to hypertension, including left ventricular hypertrophy, stroke, endstage renal disease (ESRD) and coronary artery disease. Hypertensive nephrosclerosis is particularly more prevalent in blacks compared to whites, and there is evidence that factors in addition to elevated blood pressure contribute to its pathogenesis. Transforming growth factor-beta 1(TGF-β1) is a fibrogenic cytokine that has been implicated in the development and progression of experimental and human renal diseases. We have demonstrated that blacks with ESRD have higher circulating levels of TGF-β1 protein compared to whites with ESRD. We have also found that hyperexpression of TGF-β1 is more frequent in blacks with hypertension than in whites. We propose that TGF-β1 hyperexpression may be an important mediator of hypertension and hypertensive nephrosclerosis. We hypothesize also that the increased frequency of TGF-β1hyperexpression may contribute to the excess burden of ESRD in blacks. Based on our hypotheses, and the observations that angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists reduce angiotensin II-mediated stimulation of TGF-β1 production, we propose that treatment with these agents might be efficacious in preventing or slowing the progression of target organ damage in hypertensive blacks.

AB - Hypertension is prevalent world-wide, and it affects over 50 million individuals in the United States alone. African Americans (blacks) have a high prevalence of hypertension, develop it at an earlier age, and suffer excessively from severe or malignant hypertension. They also have a high prevalence of target organ damage attributable to hypertension, including left ventricular hypertrophy, stroke, endstage renal disease (ESRD) and coronary artery disease. Hypertensive nephrosclerosis is particularly more prevalent in blacks compared to whites, and there is evidence that factors in addition to elevated blood pressure contribute to its pathogenesis. Transforming growth factor-beta 1(TGF-β1) is a fibrogenic cytokine that has been implicated in the development and progression of experimental and human renal diseases. We have demonstrated that blacks with ESRD have higher circulating levels of TGF-β1 protein compared to whites with ESRD. We have also found that hyperexpression of TGF-β1 is more frequent in blacks with hypertension than in whites. We propose that TGF-β1 hyperexpression may be an important mediator of hypertension and hypertensive nephrosclerosis. We hypothesize also that the increased frequency of TGF-β1hyperexpression may contribute to the excess burden of ESRD in blacks. Based on our hypotheses, and the observations that angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists reduce angiotensin II-mediated stimulation of TGF-β1 production, we propose that treatment with these agents might be efficacious in preventing or slowing the progression of target organ damage in hypertensive blacks.

UR - http://www.scopus.com/inward/record.url?scp=0034166728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034166728&partnerID=8YFLogxK

U2 - 10.1007/s11906-000-0080-5

DO - 10.1007/s11906-000-0080-5

M3 - Article

VL - 2

SP - 184

EP - 191

JO - Current Hypertension Reports

JF - Current Hypertension Reports

SN - 1522-6417

IS - 2

ER -